Bezbaruah R - Search Results

1

Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.

Bezbaruah R, Borah P, Kakoti BB, Al-Shar'I NA, Chandrasekaran B, Jaradat DMM, Al-Zeer MA, Abu-Romman S. Bezbaruah R, et al. Front Mol Biosci. 2021 Apr 15;8:635337. doi: 10.3389/fmolb.2021.635337. eCollection 2021. Front Mol Biosci. 2021. PMID: 33937326 Free PMC article. Review.

2

Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena.

Chavda VP, Bezbaruah R, Athalye M, Parikh PK, Chhipa AS, Patel S, Apostolopoulos V. Chavda VP, et al. Among authors: bezbaruah r. Viruses. 2022 Apr 6;14(4):759. doi: 10.3390/v14040759. Viruses. 2022. PMID: 35458489 Free PMC article. Review.

3

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.

Chavda VP, Yao Q, Vora LK, Apostolopoulos V, Patel CA, Bezbaruah R, Patel AB, Chen ZS. Chavda VP, et al. Among authors: bezbaruah r. Front Immunol. 2022 Oct 3;13:961198. doi: 10.3389/fimmu.2022.961198. eCollection 2022. Front Immunol. 2022. PMID: 36263030 Free PMC article. Review.

4

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues.

Kakoti BB, Bezbaruah R, Ahmed N. Kakoti BB, et al. Among authors: bezbaruah r. Front Pharmacol. 2022 Oct 3;13:1007315. doi: 10.3389/fphar.2022.1007315. eCollection 2022. Front Pharmacol. 2022. PMID: 36263141 Free PMC article. Review.

5

Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.

Chavda VP, Bezbaruah R, Valu D, Patel B, Kumar A, Prasad S, Kakoti BB, Kaushik A, Jesawadawala M. Chavda VP, et al. Among authors: bezbaruah r. Vaccines (Basel). 2023 Feb 13;11(2):432. doi: 10.3390/vaccines11020432. Vaccines (Basel). 2023. PMID: 36851309 Free PMC article. Review.

6

COVID-19 and vaccination: myths vs science.

Chavda VP, Chen Y, Dave J, Chen ZS, Chauhan SC, Yallapu MM, Uversky VN, Bezbaruah R, Patel S, Apostolopoulos V. Chavda VP, et al. Among authors: bezbaruah r. Expert Rev Vaccines. 2022 Nov;21(11):1603-1620. doi: 10.1080/14760584.2022.2114900. Epub 2022 Sep 1. Expert Rev Vaccines. 2022. PMID: 35980281

7

An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized Care.

Huang Z, Chavda VP, Bezbaruah R, Uversky VN, P S, Patel AB, Chen ZS. Huang Z, et al. Among authors: bezbaruah r. Front Pharmacol. 2022 Apr 1;13:866827. doi: 10.3389/fphar.2022.866827. eCollection 2022. Front Pharmacol. 2022. PMID: 35431922 Free PMC article. Review.

8

The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far.

Chavda VP, Bezbaruah R, Deka K, Nongrang L, Kalita T. Chavda VP, et al. Among authors: bezbaruah r. Vaccines (Basel). 2022 Nov 14;10(11):1926. doi: 10.3390/vaccines10111926. Vaccines (Basel). 2022. PMID: 36423021 Free PMC article. Review.

9

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update.

Chavda VP, Bezbaruah R, Dolia S, Shah N, Verma S, Savale S, Ray S. Chavda VP, et al. Among authors: bezbaruah r. Process Biochem. 2023 Apr;127:66-81. doi: 10.1016/j.procbio.2023.01.018. Epub 2023 Jan 31. Process Biochem. 2023. PMID: 36741339 Free PMC article. Review.

10

Vaccination efforts for Buruli ulcer.

Chavda VP, Haritopoulou-Sinanidou M, Bezbaruah R, Apostolopoulos V. Chavda VP, et al. Among authors: bezbaruah r. Expert Rev Vaccines. 2022 Oct;21(10):1419-1428. doi: 10.1080/14760584.2022.2113514. Epub 2022 Aug 24. Expert Rev Vaccines. 2022. PMID: 35962475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page